InvestSMART

Living Cell Technologies Limited (ASX: LCT) - Announcements

- Current share price for LCT : $0.014

ASX company news and announcements for Living Cell Technologies Limited (LCT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Living Cell Technologies Limited (LCT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Living Cell Technologies Limited (LCT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Living Cell Technologies Limited (LCT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Appendix 4C 30 Apr 2009 11:56AM $0.210 $0.014 fallen by 93.33%
$23 LCT`s New Zealand Pigs Free of Viruses 27 Apr 2009 8:46AM $0.170 $0.014 fallen by 91.76%
$23 New Zealand Clinical Trial 17 Apr 2009 3:40PM $0.145 $0.014 fallen by 90.34%
$23 Clinical Update 6 Apr 2009 11:40AM $0.110 $0.014 fallen by 87.27%
$23 Appendix 4D - Half Year Accounts 27 Feb 2009 5:10PM $0.090 $0.014 fallen by 84.44%
$23 LCT reports substained benefit with DIABECELL 11 Feb 2009 9:39AM $0.098 $0.014 fallen by 85.71%
$23 Appendix 4C - quarterly 30 Jan 2009 4:29PM $0.090 $0.014 fallen by 84.44%
$23 Cash conservation and change of CEO 23 Dec 2008 10:42AM $0.110 $0.014 fallen by 87.27%
$23 LCT`s NeurotrophinCell effective in Parkinson`s disease 11 Dec 2008 10:24AM $0.130 $0.014 fallen by 89.23%
$23 Appendix 4C - quarterly 31 Oct 2008 2:46PM n/a $0.014 n/a
$23 LCT Expands Production Facility 23 Oct 2008 10:51AM $0.195 $0.014 fallen by 92.82%
$23 LCT Receives Ministers Approval for NZ Trial 21 Oct 2008 10:03AM $0.200 $0.014 fallen by 93%
$23 Preliminary Final Report 29 Aug 2008 5:17PM $0.210 $0.014 fallen by 93.33%
$23 Appendix 4C - quarterly 31 Jul 2008 10:38AM $0.210 $0.014 fallen by 93.33%
$23 LCT Reports Clinical Benefits 22 Jul 2008 10:26AM $0.200 $0.014 fallen by 93%
$23 LCT Confirms Insulin Delivery from Implants 25 Jun 2008 12:05PM $0.270 $0.014 fallen by 94.81%
$23 LCT Expands Diabetes Clinical Trial 5 Jun 2008 10:09AM $0.310 $0.014 fallen by 95.48%
$23 LCT lists on International OTCQX 3 Jun 2008 9:26AM $0.320 $0.014 fallen by 95.63%
$23 Appendix 4C - quarterly 30 Apr 2008 10:56AM $0.290 $0.014 fallen by 95.17%
$23 LCT Announces Compelling Results 31 Mar 2008 9:24AM $0.310 $0.014 fallen by 95.48%
$23 LCT ISSUED FOURTH US PATENT FOR DIABECELL 17 Mar 2008 1:04PM $0.280 $0.014 fallen by 95%
$23 Half Yearly Report and Accounts 29 Feb 2008 12:28PM $0.280 $0.014 fallen by 95%
$23 LCT and US based Barbara Davis Center collaborate on trial 27 Feb 2008 12:31PM $0.300 $0.014 fallen by 95.33%
$23 Diabetes Trial Supported By US-Based Diabetes Foundation 12 Feb 2008 9:57AM $0.270 $0.014 fallen by 94.81%
$23 Appendix 4C - quarterly 31 Jan 2008 10:53AM $0.300 $0.014 fallen by 95.33%

501 - 525 of 584 results

Page 21 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.